Streetbeat News

Regulatory

SOHO

Sotherly Hotels has received a notice from Nasdaq for failing to timely file its quarterly report for Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 6:04 pm

FXI

VGK

The European Commission will delay its decision on Chinese electric vehicle tariffs until after the European Parliament election on June 9. The provisional tariffs, expected by June 5, would have imposed significant costs on Chinese EV makers. The new deadline is June 10, though it may be due to a technical issue.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 5:58 pm

DJT

TSLA

Elon Musk, CEO of Tesla Inc (NASDAQ:TSLA), is reportedly in discussions with Donald Trump about a potential advisory role if Trump wins the 2024 presidential election. This role could influence policies on electric vehicles, border security, technology, science, space exploration, and the economy. Musk has had a contentious relationship with President Biden and has criticized his pro-union policies. Musk and Trump have had a rocky relationship but seem to be rebuilding it, which could lead to a public endorsement from Musk.

Portfolio Pulse from Chris Katje

May 29, 2024 | 5:36 pm

KBE

KRE

VGK

XLF

The European Central Bank (ECB) is set to impose fines on several banks for failing to address climate change risks. Up to four lenders may face penalties for not meeting ECB deadlines for climate risk assessment. The fines, which can be up to 5% of daily revenue, may be largely symbolic.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 5:25 pm

BA

Boeing CEO David Calhoun is scheduled to meet with FAA Administrator Michael Whitaker to discuss Boeing's quality plan. This meeting could have significant implications for Boeing's regulatory compliance and future operations.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 5:06 pm

AMGN

AZN

The FDA has approved Amgen's Bkemv as the first interchangeable biosimilar to AstraZeneca's Soliris for treating rare diseases PNH and aHUS. This approval marks the 53rd biosimilar in the U.S. and the 13th interchangeable one.

Portfolio Pulse from Vandana Singh

May 29, 2024 | 4:51 pm

UUP

The upcoming U.S. elections in November 2024 are expected to be a significant risk event for asset markets. Goldman Sachs outlines potential impacts on equities, yields, and the US Dollar (USD) based on different election outcomes. A Trump victory is likely to lead to a stronger USD, with the Invesco DB USD Index Bullish Fund ETF (NYSE:UUP) expected to see a 3.6% increase. The first presidential debate on June 27 is anticipated to be a key market-moving event.

Portfolio Pulse from Piero Cingari

May 29, 2024 | 4:33 pm

AZUL

Azul's CEO stated that Gol informed Brazil's antitrust regulator, Cade, about their codeshare agreement before its announcement. The CEO does not foresee any antitrust issues with the deal.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 4:31 pm

LLY

The FDA has granted accelerated approval to Eli Lilly's Retevmo for pediatric patients with advanced thyroid cancer and RET gene fusion. This marks the first targeted therapy approved for patients under 12 with RET alterations.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 4:30 pm

TSLA

The U.S. Auto Safety Agency is seeking records from Tesla regarding a probe into potential power steering loss issues.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 4:28 pm